Open AccessP576: A PHASE I/II STUDY OF MILADEMETAN (DS3032B) IN COMBINATION WITH LOW DOSE CYTARABINE WITH OR WITHOUT VENETOCLAX IN ACUTE MYELOID LEUKEMIA
Author(s) -
Senapati J.,
Ishizawa J.,
Abbas H. A.,
Loghavi S.,
Borthakur G.,
Issa G. C.,
Dara S. I.,
Pourebrahim R.,
Daver N.,
Jabbour E. J.,
Kornblau S. M.,
Pemmaraju N.,
GarciaManero G.,
Ravandi F.,
Muftuoglu M.,
Khoury J.,
DiNardo C.,
Andreeff M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845192.65192.c0
Subject(s) - medicine , cytarabine , tolerability , venetoclax , oncology , myeloid leukemia , phases of clinical research , leukemia , transplantation , gastroenterology , adverse effect , toxicity , chronic lymphocytic leukemia